首页 | 本学科首页   官方微博 | 高级检索  
     


A phase 3, multicenter,randomized, allopurinol‐controlled study assessing the safety and efficacy of oral febuxostat in Chinese gout patients with hyperuricemia
Authors:Shaoyong Xu  Xiangyang Liu  Jie Ming  Shenren Chen  Yangang Wang  Xiumei Liu  Hong Liu  Yongde Peng  Jianqin Wang  Jinying Lin  Haiwang Ji  Bin Liu  Ying Lu  Peng Liu  Yonghong Zhang  Qiuhe Ji
Affiliation:1. Department of Endocrinology, Xijing Hospital, Fourth Military Medical University, Xi'an, China;2. Department of Endocrinology, the Second Affiliated Hospital of Shantou University Medical College, Shantou, China;3. Department of Endocrinology, the Affiliated Hospital of Qingdao University, Qingdao, China;4. Department of Rheumatology, the First Hospital of Shanxi Medical University, Taiyuan, China;5. Department of Endocrinology, the First Affiliated Hospital of Guangxi Medical University, Nanning, China;6. Department of Endocrinology, Shanghai General Hospital, Shanghai, China;7. Department of Nephrology, Lanzhou University Second Hospital, Lanzhou, China;8. Department of Hematology, the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China;9. Department of Traditional Chinese Medicine and Rheumatology, Shaanxi Provincial People's Hospital, Xi'an, China;10. Department of Hand and Foot Surgery, the First Hospital of Jilin University, Jilin, China;11. Department of Nephrology, Zhejiang Provincial Tongde Hospital, Hangzhou, China;12. Department of Endocrinology, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, China;13. Department of Rheumatology, Luoyang Orthopedic‐Traumatological Hospital, Luoyang, China
Abstract:
Keywords:allopurinol  febuxostat  gout  hyperuricemia
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号